Enzo Biochem, Inc. / Fundamentals
Income statement
- Net revenue
€23.67M - Cost of goods sold
€13.31M - Gross profit
€10.36M - SG&A expenses
€19.48M - R&D expenses
€1.85M - EBITDA
-€8.11M - D&A
€1.17M - EBIT
-€9.24M - Interest expenses
€169.73K - EBT
-€6.76M - Tax expenses
€510.04K - Net income
-€18.16M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€3.80M - Changes in working capital
€7.11M - Operating cash flow
-€13.20M - Capex
€884.81K - Other investing cash flow
€4.31M - Net investing cash flow
€3.42M - Total cash dividends paid
-€9.17M - Issuance of common stock
€0.00 - Debt repayment
-€3.18M - Other financing cash flow
€4.45M - Net financing cash flow
-€7.90M - Foreign exchange effects
€51.69K - Net change in cash
-€17.63M - Cash at end of period
€31.61M - Free cash flow
-€12.31M
Balance sheet
- Cash and cash equivalents
€31.61M - Cash and short-term investments
€31.61M - Total receivables
€3.71M - Inventory
€4.92M - Other current assets
€1.35M - Total current assets
€41.59M - Property, plant & equipment
€12.80M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€332.56K - Total non-current assets
€13.13M - Total assets
€54.72M - Accounts payable
€1.20M - Short-term debt
€821.92K - Other current liabilities
€12.63M - Total current liabilities
€14.66M - Long-term debt
€1.77M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€911.52K - Total non-current liabilities
€2.68M - Total liabilities
€17.33M - Common stock
€450.59K - Retained earnings
-€260.30M - Other equity
€1.44M - Total equity
€37.39M - Total liabilities and shareholders' equity
€54.72M
Company information
- Market capitalization
€14.03M - Employees
125 - Enterprise Value
-€6.24M
Company ratios
- Gross margin
-
43.8% Better than peer group: 27.4% - EBITDA margin
-
-34.3% Much better than peer group: -1,337.8% - EBIT margin
-
-39.0% Much better than peer group: -1,436.7% - EBT margin
-
-28.5% Much better than peer group: -1,425.7% - Net margin
-
-76.7% Much better than peer group: -1,423.7% - ROE
-
-48.6% Much worse than peer group: 28.2% - ROA
-
-33.2% Worse than peer group: -22.9% - Asset turnover
-
43.3% Much worse than peer group: 76.2% - FCF margin
-
-59.5% Much better than peer group: -1,158.5% - FCF yield
-100.4% - Efficiency ratio
134.3% - Net sales per employee
-
€189.37K - Net income per employee
-
-€145.31K